These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6134672)

  • 1. Adverse reactions with calcium antagonists.
    Krebs R
    Hypertension; 1983; 5(4 Pt 2):II125-9. PubMed ID: 6134672
    [No Abstract]   [Full Text] [Related]  

  • 2. Calcium-channel blocking agents.
    Leonard RG; Talbert RL
    Clin Pharm; 1982; 1(1):17-33. PubMed ID: 6764159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse reactions to calcium antagonists.
    Lewis JG
    Drugs; 1983 Feb; 25(2):196-222. PubMed ID: 6339200
    [No Abstract]   [Full Text] [Related]  

  • 4. [Calcium antagonists in arterial hypertension].
    Muiesan G
    G Ital Cardiol; 1988 Nov; 18(11):982-8. PubMed ID: 3073993
    [No Abstract]   [Full Text] [Related]  

  • 5. Negative inotropic activity of the calcium antagonists isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardium.
    Schwinger RH; Böhm M; Erdmann E
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):185S-187S. PubMed ID: 1827017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of calcium antagonists in the therapy of coronary heart disease].
    Meyer J
    Internist (Berl); 1983 Jul; 24(7):408-14. PubMed ID: 6136492
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of the cardiovascular adversity of the calcium antagonist beta-blocker combination: implications for antihypertensive therapy.
    Brouwer RM; Follath F; Bühler FR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 4():S38-44. PubMed ID: 2412010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous reactions due to diltiazem and cross reactivity with other calcium channel blockers.
    Gonzalo Garijo MA; Pérez Calderón R; de Argila Fernández-Durán D; Rangel Mayoral JF
    Allergol Immunopathol (Madr); 2005; 33(4):238-40. PubMed ID: 16045866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact dermatitis caused by diltiazem cream and cross-reactivity with other calcium channel blockers.
    Forkel S; Baltzer AB; Geier J; Buhl T
    Contact Dermatitis; 2018 Oct; 79(4):244-246. PubMed ID: 29851108
    [No Abstract]   [Full Text] [Related]  

  • 10. Adverse Drug Reactions Advisory Committee. Gynaecomastia in association with calcium antagonists.
    Boyd IW
    Med J Aust; 1994 Sep; 161(5):328. PubMed ID: 7830672
    [No Abstract]   [Full Text] [Related]  

  • 11. Selectivity of Ca
    Takahara A; Nozaki S; Ishiguro A; Okamura K; Cao X; Aimoto M; Nagasawa Y
    J Pharmacol Sci; 2018 May; 137(1):98-100. PubMed ID: 29709270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gingival hyperplasia due to calcium antagonists.
    Prescrire Int; 1998 Apr; 7(34):54-5. PubMed ID: 10183386
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating coexisting cardiovascular and pulmonary disease with calcium antagonists.
    Berman BA; Ross RN
    Ann Allergy; 1986 Mar; 56(3):195-200. PubMed ID: 2420238
    [No Abstract]   [Full Text] [Related]  

  • 14. [Calcium antagonists in the therapy of hypertension].
    Heidland A; Heidbreder E; Hörl WH; Schäfer RM
    Klin Wochenschr; 1983 Jul; 61(13):633-40. PubMed ID: 6350692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation by nifedipine and diltiazem of the hypotensive response after contrast angiography.
    Morris DL; Wisneski JA; Gertz EW; Wexman M; Axelrod R; Langberg JJ
    J Am Coll Cardiol; 1985 Oct; 6(4):785-91. PubMed ID: 4031293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Slow channel blockers.
    Covinsky JO; Hamburger SC
    South Med J; 1983 Jan; 76(1):55-64. PubMed ID: 6337401
    [No Abstract]   [Full Text] [Related]  

  • 17. Calcium channel blockers in systemic hypertension.
    Frishman WH; Charlap S; Michelson EL
    Am J Cardiol; 1986 Jul; 58(1):157-60. PubMed ID: 3524178
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Side-effects of calcium antagonists].
    Fossati C; Guistiniani S
    Clin Ter; 1984 Jun; 109(6):569-74. PubMed ID: 6236948
    [No Abstract]   [Full Text] [Related]  

  • 20. Calcium-entry blocking agents in the treatment of systemic hypertension.
    Robinson BF
    Am J Cardiol; 1985 Jan; 55(3):102B-106B. PubMed ID: 2857516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.